Mirena

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

ContraceptionHyperplasiaAtypical Endometrial Hyperplasia

102 competitors in Contraception

#DrugCompanyPhaseTrials

1

Carbocaine

Pfizer

Phase 3

12

Depo-Provera

Eli Lilly

Phase 3

—3

Feldene

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

24

Estradiol Valerate

Bayer

Phase 3

—5

Yasmin

Bayer

Phase 3

16

Opill

LLaboratoire français de Fractionnement et de Biotechnologies

Phase 3

17

Mirena

Bayer

Phase 3

48

Norethindrone Acetate

WWatson Pharmaceuticals

Phase 3

29

Marvelon

Bayer

Phase 3

110

Levonorgestrel and Ethinyl Estradiol

Pfizer

Phase 3

2Show 25 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Contraception4 trials

Duration of Use of Highly Effective Reversible Contraception

Completed·Bayer··NCT02414919·13,880 enrolled

HR-QoL and Sexuality in Mirena Inserted Contraception Users

Completed·Bayer·Phase 4·NCT00498784·141 enrolled

Long-Acting Reversible Contraception

Completed·FFHI 360·Phase 4·NCT01299116·916 enrolled

Show 1 more trial

A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

Terminated·MMedicines360·Phase 3·NCT00995150·1,910 enrolled

Heavy Menstrual Bleeding1 trial

Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

Completed·UUteron Pharma S.A.·Phase 3·NCT01695902·280 enrolled

Bleeding1 trial

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Completed·Bayer·Phase 4·NCT01295294·187 enrolled

Trial1 trial

Scandinavian Mirena Insertion Nulliparous Trial.

Completed·Bayer··NCT00798980·224 enrolled

Systemic1 trial

Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

Terminated·TThomas Cherpes, DVM, MD··NCT01750476·7 enrolled

6 more indications

Cohort Study1 trial

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

Completed·UUniversity of Colorado, Denver··NCT02067663·123 enrolled

Hyperplasia1 trial

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Not yet recruiting·UUniversity Health Network, Toronto·Phase 2·NCT06073184·71 enrolled

Atypical Endometrial Hyperplasia1 trial

A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

Unknown status·KKK Women's and Children's Hospital·Phase 2·NCT05492487·60 enrolled

Women1 trial

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

Terminated·Bayer·Phase 2·NCT02490774·174 enrolled

Menopause1 trial

Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

Completed·UUniversity of Colorado, Denver·N/A·NCT01613131·39 enrolled

Unspecified1 trial

Mirena Efficiency and Tolerability During the First Year of Use

Completed·Bayer·Phase 4·NCT00696202·199 enrolled

Details

Drug Info

Related News